TABLE 6.

Clinical success rate at test of cure for typical pretherapy pathogensa

Patient group or pathogenNo. of successes/no. in group (% successes)
Bacteriology ITT populationBacteriology PP population
2,000/125 mg875/125 mg2,000/125 mg875/125 mg
Patients with at least one typical pathogen87736751
S. pneumoniae b 32/33 (97.0)19/28 (67.9)26/27 (96.3)16/19 (84.2)
H. influenzae 17/20 (85.0)12/13 (92.3)14/16 (87.5)10/10 (100)
Methicillin-susceptible15/16 (93.8)12/18 (66.7)11/11 (100)11/13 (84.6)
Staphylococcus aureus
M. catarrhalis 3/4 (75.0)3/3 (100)1/2 (50.0)2/2 (100)
  • a See Table 3, footnote a.

  • b There were 33 S. pneumoniae isolates from 31 patients with this pathogen in the amoxicillin-clavulanate 2,000/125 mg group; there were 28 S. pneumoniae isolates from 27 patients with the pathogen in the amoxicillin-clavulanate 875/125 mg group.